Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions

Published:2023-10 Issue:10 Volume:26 Page:107881
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Yang Ling,Zhuang Li,Ye Zhaoyang,Li Linsheng,Guan Jingzhi,Gong Wenping^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference190 articles.

1. Lung cancer: Epidemiology, etiology, and prevention;Dela Cruz;Clin. Chest Med.,2011

2. Cancer statistics;Siegel;CA A Cancer J. Clin.,2022

3. Cancer statistics in china and united states, 2022: Profiles, trends, and determinants;Xia;Chin. Med. J.,2022

4. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021

5. Global epidemiology of tuberculosis and progress toward meeting global targets - worldwide, 2018;MacNeil;MMWR Morb. Mortal. Wkly. Rep.,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decision model for durable clinical benefit from front- or late-line immunotherapy alone or with chemotherapy in non-small cell lung cancer;Med;2024-08

2. Visualization analysis of research progress and trends in coexistence of lung cancer and pulmonary tuberculosis using bibliometrics;Medicine Advances;2024-06

3. Deciphering the Correlation between the Emergence of Lung Carcinoma Associated with Tuberculosis-related Inflammation;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-05-31

4. Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection;Molecular Biomedicine;2024-04-29

5. Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective;Exploration;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3